Published in Br J Cancer on July 20, 2001
Participation in genetic testing research varies by social group. Public Health Genomics (2010) 1.79
The GRAIDS Trial: a cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. Br J Cancer (2007) 1.43
Referrals of women with a family history of breast cancer from primary care to cancer genetics services in South East Scotland. Br J Cancer (2003) 1.21
Patient satisfaction with two different models of cancer genetic services in south-east Scotland. Br J Cancer (2004) 1.15
What motivates interest in attending a familial cancer genetics clinic? Fam Cancer (2003) 1.04
Risk assessment and management of high risk familial breast cancer. J Med Genet (2002) 1.01
Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans. J Med Genet (2004) 0.98
A randomised controlled trial of breast cancer genetics services in South East Scotland: psychological impact. Br J Cancer (2003) 0.95
What hinders minority ethnic access to cancer genetics services and what may help? Eur J Hum Genet (2013) 0.90
Who is being referred to cancer genetic counseling? Characteristics of counselees and their referral. J Community Genet (2012) 0.89
Genetic nurse counsellors can be an acceptable and cost-effective alternative to clinical geneticists for breast cancer risk genetic counselling. Evidence from two parallel randomised controlled equivalence trials. Br J Cancer (2006) 0.88
Referrals of patients to colorectal cancer genetics services in south-east Scotland. Fam Cancer (2005) 0.85
A randomised comparison of UK genetic risk counselling services for familial cancer: psychosocial outcomes. Br J Cancer (2004) 0.83
Genetic research participation in a young adult community sample. J Community Genet (2014) 0.83
The challenge of developing evidence-based genetics health care in practice. Fam Cancer (2006) 0.83
Delivering cancer genetics services--new ways of working. Fam Cancer (2007) 0.82
Familial colorectal cancer referral to regional genetics department--a single centre experience. Fam Cancer (2007) 0.82
Familial breast cancer: management of 'lower risk' referrals. Br J Cancer (2006) 0.81
Improving access to cancer genetics services in primary care: socio-economic data from North Kirklees. Fam Cancer (2007) 0.80
Breast cancer genetic counselling referrals: how comparable are the findings between the UK and the Netherlands? J Community Genet (2011) 0.80
A cross-sectional survey to estimate the prevalence of family history of colorectal, breast and ovarian cancer in a Scottish general practice population. Br J Cancer (2004) 0.78
Nurse-led cancer genetics clinics in primary and secondary care in varied ethnic population areas: interaction with primary care to improve ascertainment of individuals from ethnic minorities. Fam Cancer (2007) 0.77
A clinical and genetic analysis of multiple primary cancer referrals to genetics services. Eur J Hum Genet (2014) 0.77
The geography of genetics: an analysis of referral patterns to a cancer genetics service. Genomic Med (2008) 0.75
Patient perspectives on the Poole PCT cancer genetics service. Fam Cancer (2007) 0.75
Evaluation after five years of the cancer genetic counselling programme of Valencian Community (Eastern Spain). Fam Cancer (2014) 0.75
Delivery of cancer genetics services: The Royal Marsden telephone clinic model. Fam Cancer (2007) 0.75
Computer support for interpreting family histories of breast and ovarian cancer in primary care: comparative study with simulated cases. BMJ (2000) 3.12
Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer. J Natl Cancer Inst (1999) 2.99
Theories in health care and research: theories of masculinity. BMJ (1998) 2.05
Evaluation of questionnaire on cancer family history in identifying patients at increased genetic risk in general practice. BMJ (1999) 1.97
Randomized trial of a specialist genetic assessment service for familial breast cancer. J Natl Cancer Inst (2000) 1.92
Setting up and running a familial cancer clinic. Br Med Bull (1994) 1.11
Genetic counselling in the cancer family clinic. Eur J Cancer (1994) 1.00
Genetic counselling for hereditary breast cancer. Lancet (1999) 0.93
Genetic services for familial cancer patients: a survey of National Cancer Institute cancer centers. J Natl Cancer Inst (1995) 0.93
Cancer genetics services in Europe. Dis Markers (1999) 0.90
Cancer genetics services in Northern Ireland. Dis Markers (1999) 0.83
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst (1993) 38.99
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer (1976) 22.55
Small-area variations in the use of common surgical procedures: an international comparison of New England, England, and Norway. N Engl J Med (1982) 12.33
Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet (1991) 12.30
Cancer patients' information needs and information seeking behaviour: in depth interview study. BMJ (2000) 8.44
Molecular analysis of cellulose biosynthesis in Arabidopsis. Science (1998) 7.51
Mental health of hospital consultants: the effects of stress and satisfaction at work. Lancet (1996) 7.44
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet (2008) 6.50
Impact of postmenopausal hormone therapy on cardiovascular events and cancer: pooled data from clinical trials. BMJ (1997) 6.32
Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol (1997) 5.89
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project--1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry (1990) 5.82
Increasing use of private practice by patients in Oxford requiring common elective surgical operations. Br Med J (Clin Res Ed) (1985) 5.49
Statistics: the problem of examining accumulating data more than once. N Engl J Med (1974) 5.09
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever stroke. J Neurol Neurosurg Psychiatry (1988) 4.98
Regional variations in the use of common surgical procedures: within and between England and Wales, Canada and the United States of America. Soc Sci Med A (1981) 4.88
Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet (2001) 4.71
Relation between general practices' outpatient referral rates and rates of elective admission to hospital. BMJ (1990) 4.66
Mortality among appropriately referred patients refused admission to intensive-care units. Lancet (1997) 4.65
Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). J Med Genet (2007) 4.62
Will payment based on diagnosis-related groups control hospital costs? N Engl J Med (1984) 4.56
Burnout and psychiatric disorder among cancer clinicians. Br J Cancer (1995) 4.47
The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer. Br J Psychiatry (1991) 4.43
DiGeorge syndrome: part of CATCH 22. J Med Genet (1993) 4.30
Diagnostic dilatation and curettage: is it used appropriately? BMJ (1993) 4.28
Breast cancer and hormonal supplements in postmenopausal women. BMJ (1995) 4.16
Mass spectrometry and EST-database searching allows characterization of the multi-protein spliceosome complex. Nat Genet (1998) 4.16
Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet (1992) 4.07
Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med (1989) 3.97
Methods in health services research. Interpreting the evidence: choosing between randomised and non-randomised studies. BMJ (1999) 3.96
Third generation oral contraception and venous thromboembolism. BMJ (1996) 3.76
The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol (1996) 3.68
Hypernatraemia in infants as a cause of brain damage. Arch Dis Child (1967) 3.53
Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill. Lancet (1983) 3.53
Socioeconomic variations in the use of common surgical operations. Br Med J (Clin Res Ed) (1985) 3.46
Do British women undergo too many or too few hysterectomies? Soc Sci Med (1988) 3.45
Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet (1985) 3.42
Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet (1997) 3.41
Integration of general-practitioner and specialist antenatal care. J R Coll Gen Pract (1978) 3.39
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol (2008) 3.31
Threats to applicability of randomised trials: exclusions and selective participation. J Health Serv Res Policy (1999) 3.23
Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut (2010) 3.22
Epidemiology and clinical significance of cervical erosion in women attending a family planning clinic. Br Med J (1978) 3.20
Ratio of waist circumference to height may be better indicator of need for weight management. BMJ (1996) 3.17
Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet (2001) 3.15
The epidemiology of hysterectomy: findings in a large cohort study. Br J Obstet Gynaecol (1992) 2.99
Removing barriers to career development in public health. BMJ (2000) 2.82
Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics. J Med Genet (2008) 2.81
Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies. Am J Clin Nutr (1999) 2.78
A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer. Ann Oncol (1997) 2.71
Risk of death from cancer and ischaemic heart disease in meat and non-meat eaters. BMJ (1994) 2.70
Molecular genetic study of the frequency of monosomy 22q11 in DiGeorge syndrome. Am J Hum Genet (1992) 2.70
Adjuvant psychological therapy for patients with cancer: a prospective randomised trial. BMJ (1992) 2.68
Preferential deletion of exons in Duchenne and Becker muscular dystrophies. Nature (1987) 2.67
Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut (2008) 2.65
X-linked situs abnormalities result from mutations in ZIC3. Nat Genet (1997) 2.62
A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol Cell (2001) 2.61
Response of women aged 65-74 to invitation for screening for breast cancer by mammography: a pilot study in London, UK. J Epidemiol Community Health (1996) 2.61
Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires. J Clin Oncol (1999) 2.59
For and against: Public health does not need to be led by doctors. For. BMJ (2001) 2.57
Hyponatraemia: mechanisms and management. Lancet (1981) 2.55
Reduction in total under-five mortality in western Nepal through community-based antimicrobial treatment of pneumonia. Lancet (1991) 2.54
Familial breast cancer. BMJ (1994) 2.54
Is short stature a handicap? A comparison of the psychosocial functioning of referred and nonreferred children with normal short stature and children with normal stature. J Pediatr (2000) 2.52
Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development. Dev Biol (2000) 2.50
Choosing between randomised and non-randomised studies: a systematic review. Health Technol Assess (1998) 2.49
The frequency distributions of commonly determined blood constituents in healthy blood donors. Clin Chim Acta (1974) 2.49
A homeobox gene, HLXB9, is the major locus for dominantly inherited sacral agenesis. Nat Genet (1998) 2.48
VACTERL with hydrocephalus: one end of the Fanconi anemia spectrum of anomalies? Am J Med Genet (1992) 2.47
The painful arc syndrome. Clinical classification as a guide to management. J Bone Joint Surg Br (1977) 2.44
Measuring the impact of menopausal symptoms on quality of life. BMJ (1993) 2.42
An assessment of prostatectomy for benign urinary tract obstruction. Geographic variations and the evaluation of medical care outcomes. JAMA (1988) 2.42
Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynaecol (1990) 2.41
Fertility after stopping different methods of contraception. Br Med J (1978) 2.40
Utilisation of hormone replacement therapy by women doctors. BMJ (1995) 2.35
Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol (1987) 2.34
Perception of risk in women with a family history of breast cancer. Br J Cancer (1993) 2.32
Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer--a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine Group. Non-Small Cell Lung Cancer. Br J Cancer (2000) 2.30
Deletions within chromosome 22q11 in familial congenital heart disease. Lancet (1992) 2.29
A prospective cytogenetic study of 36 cases of DiGeorge syndrome. Am J Hum Genet (1992) 2.23
Hardy-Weinberg quality control. Ann Hum Genet (1999) 2.22
Confirmation that the velo-cardio-facial syndrome is associated with haplo-insufficiency of genes at chromosome 22q11. Am J Med Genet (1993) 2.21
Teenagers and their health. Arch Dis Child (1987) 2.20
Characterization of the supernumerary chromosome in cat eye syndrome. Science (1986) 2.19
Home safety education and provision of safety equipment for injury prevention. Cochrane Database Syst Rev (2007) 2.18
European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17
Familial cancer syndromes. Lancet (1994) 2.16
Oral contraceptives and breast cancer. Lancet (1983) 2.16
Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol Biomarkers Prev (2001) 2.14
Monozygotic twins with chromosome 22q11 deletion and discordant phenotype. J Med Genet (1995) 2.13
HRT: an analysis of benefits, risks and costs. Br Med Bull (1992) 2.11
Modelling the effects of increased physical activity on coronary heart disease in England and Wales. J Epidemiol Community Health (1997) 2.08
Comparison of costs to the health sector of comprehensive and episodic health care for sickle cell disease patients. Public Health Rep (1995) 2.08